Vaccine maker Moderna says it has filed for emergency use authorization for its coronavirus vaccine.
“Moderna’s data for the Emergency Use Authorization request for mRNA-1273 has been submitted to the U.S. FDA,” the company said in a tweet from its official Twitter account.
Earlier, the US Food and Drug Administration said it had scheduled a meeting of its vaccine advisers, the Vaccines and Related Biological Products Advisory Committee, for December 17 to consider Moderna’s EUA. But the FDA cannot confirm the submission. Only the company can do so – and now it has.